NCT Number: NCT01528956
Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research trial studies genes in samples from younger patients with adrenocortical tumor.
Looking for future studies?
Notify MeKey information
Conditions
Age range
Up to 21 year
Sex eligibility
All sexes
Study type
Observational
About this study
OBJECTIVES:
- To perform whole-genome sequencing, deep sequencing, micro RNA analysis, methylation status, copy number variation analysis, and single-nucleotide polymorphisms (SNPs) analysis in pediatric adrenocortical tumors and compare those results to those of the same patient's normal cells.
OUTLINE: Archived tumor and blood samples are analyzed for whole-genome sequencing, deep sequencing, micro RNA , methylation status, copy variation, and single-nucleotide polymorphisms. Results are then compared with patients' normal cells.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Banked tumor and blood samples obtained from patients enrolled on COG-ARAR0332 in North America and Brazil
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Treatment and study plan
RNA analysis
Geneticgene expression analysis
Geneticnucleic acid sequencing
Geneticpolymorphism analysis
GeneticPrimary outcomes
-
Identification of genetic factors affecting adrenocortical tumors
-
Comprehensive catalog of altered genes in adrenocortical samples
Sponsors and collaborators
Lead sponsor
Children's Oncology Group
Network
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
Using New Approaches for Genomics Studies in Pediatric Adrenocortical Tumors: Whole Genome Sequencing; Deep Sequencing; miRNA; methDNA and SNP 6.0
Important dates
- Study start
- 2012
- Primary completion
- 2016
- First posted
- Feb 8, 2012
- Registry last updated
- May 18, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield
NCT02324647
Adenocarcinoma, Adrenal Cortex Diseases
Groningen, Provincie Groningen, Netherlands
View Trial DetailsA Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
NCT00924989
Adenocarcinoma, Adrenal Cortex Diseases
Scottsdale, Arizona, United States
View Trial DetailsAdjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma
NCT03723941
Adenocarcinoma, Adrenal Cortex Diseases
Brescia, BS, Italy
View Trial DetailsStudy of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
NCT04373265
ACTH Syndrome, Ectopic, Adenocarcinoma
Stanford, California, United States
View Trial Details